Skip to main content
Log in

Assessing cost of Prader-Willi syndrome in the US

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Millendo Therapeutics US, Inc.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Assessing cost of Prader-Willi syndrome in the US. PharmacoEcon Outcomes News 855, 3 (2020). https://doi.org/10.1007/s40274-020-6868-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6868-4

Navigation